德展健康：已回购4319.94万股 使用资金总额1.19亿元

Core Viewpoint - The company, Dezhan Health (000813), has announced a share repurchase plan to enhance shareholder value and reduce registered capital [1] Group 1: Share Repurchase Plan - The board and shareholders' meetings are scheduled for July 1 and July 18, 2024, to approve the share repurchase plan [1] - The company plans to use between 200 million and 300 million yuan of its own funds and bank loans for the repurchase, with a maximum buyback price of 3.59 yuan per share [1] - The repurchased shares will be used for cancellation to reduce the company's registered capital [1] Group 2: Repurchase Progress - As of May 26, 2025, the company has repurchased a total of 43.1994 million shares, accounting for 2.00% of the total share capital [1] - The highest transaction price during the repurchase was 3.29 yuan per share, while the lowest was 2.39 yuan per share [1] - The total amount spent on the repurchase reached 119 million yuan, excluding transaction fees [1]